Cancer metabolism adapts the metabolic network of its tissue-of-origin. However, breast 2 cancer is not a disease of a singular origin. Multiple epithelial populations serve as the 3 culprit cell-of-origin for specific breast cancer subtypes, yet knowledge surrounding the 4 metabolic network of normal mammary epithelial cells is limited. Here, we show that 5 mammary populations have cell type-specific metabolic programs. Primary human breast 6 cell proteomes of basal, luminal progenitor, and mature luminal populations revealed their 7 unique enrichment of metabolic proteins. Luminal progenitors had higher abundance of 8 electron transport chain subunits and capacity for oxidative phosphorylation, whereas 9 basal cells were more glycolytic. Targeting oxidative phosphorylation and glycolysis with 10 inhibitors exposed distinct metabolic vulnerabilities of the mammary lineages. 11 Computational analysis indicated that breast cancer subtypes retain metabolic features 12 of their putative cell-of-origin. Lineage-restricted metabolic identities of normal mammary 13 cells partly explain breast cancer metabolic heterogeneity and rationalize targeting 14 subtype-specific metabolic vulnerabilities to advance breast cancer therapy. 15 16 17 18 RESULTS Abundance 3 To discover protein distinctions of primary human MEC populations we generated their 4 global proteomes. We performed mass spectrometry-based shotgun proteomics on 5 equivalent numbers of FACS-purified basal (CD45 -CD31 -CD49f hi EpCAM lo-med ; color-6 coded as red in all figures), luminal progenitor (CD45 -CD31 -CD49f lo EpCAM med ; light 7 blue), and mature luminal (CD45 -CD31 -CD49f hi EpCAM lo ; dark blue) cells from 10 normal 8 human breast samples obtained from reduction mammoplasties (Figure 1B, S1A ). Our 9 patient cohort represented diverse physiologies, covering a wide age range (28-67 years 10 old) and sex hormone status (3 luteal, 3 follicular, 4 post-menopausal). We detected 6034 11 unique proteins ( Figure 1B) . Expression of known markers for each mammary cell type 12 was accurately captured by our proteomics data (Figure S1B); higher abundance of 13 Vimentin and ITGA6 (Integrin α6, CD49f) was seen in basal cells, higher KIT and 14 ALDH1A3 levels in luminal progenitors, and higher GATA3, FOXA1 and KRT8/18 15 (Cytokeratin 8/18) in the mature luminal. Principal component analysis highlighted the 16 distinct proteomes of mammary cells; the dominant clustering feature was mammary cell 17 type with a minor segregation of post-menopausal samples within each cluster (Figure 18
INTRODUCTION 1
Molecular classification of breast cancers using the PAM50 classifier has identified 5 main 2 patient groups (Luminal A, Luminal B, HER2, Claudin-low, Basal-like) with distinct 3 transcriptional programs, survival outcomes and susceptibilities to anti-cancer regimens 1-4 of membrane proteins, whereas mature luminal demonstrated abundance for proteins 23 with pleotropic functions that were annotated as neutrophil terms (Figure S1D and S1E).
24
A metabolic network is defined as the core set of metabolic proteins essential for 25 the structure and function of a cell 13 . We first filtered the total proteomes for metabolic 26 proteins using a curated list of 2753 metabolic enzymes, transporters and subunits 31 . One 27 sixth (1020/6034) of our global mammary proteomic dataset was classified with this 28 annotation ( Figure 1B) . Unsupervised hierarchical clustering of the metabolic proteome 29 clustered based on mammary lineages ( Figure 1D ). To determine the metabolic network 30 functioning within each MEC, we sought proteins that were significantly abundant in one 31 population versus the other two (One-way ANOVA in conjunction with a Tukey's test, 32 P<0.05). The resulting metabolic networks for basal, mature luminal and luminal 33 progenitor were composed of 45, 123, 179 metabolic proteins, respectively (significant 34 hits bar in Figure 1D ). Pathway analysis using Enrichr 32,33 revealed unique GO Biological 35 Processes enriched in each metabolic network as found in Figure 1E . We also 36 constructed a global map of MEC metabolism ( Figure S2 ) using a published template 34 37 and one focused on glucose metabolism ( Figure 1F) , where we color-coded proteins to 38 show their corresponding MEC-specificity. 1 displayed an abundance of glycolytic enzymes (PFKM, ALDOC, GAPDH and PKM); 2 PFKM and PKM perform two of three key irreversible phosphorylation events in glycolysis 3 ( Figure 1F ). In the mature luminal metabolic network, we noted diverse pathways relating 4 to neutrophil activity, glutamine and glutathione ( Figure 1E ). It was also enriched for 5 enzymes in hexose and fructose metabolism such as FBP1, ALDOA and LDHB; LDHB 6 diverts pyruvate from the TCA cycle by converting it to lactate ( Figure 1F ). It was striking 7 that the top 10 pathways in luminal progenitors related to oxidative phosphorylation 8 (OXPHOS; Figure 1E ), demonstrating greater abundance of the majority of electron 9 transport chain (ETC) subunits as well as nearly all enzymes in the TCA cycle ( Figure   10 1F). MECs had isozyme-specific expression of IDH (mitochondrial IDH3 in basal cells, 11 IDH2 in luminal progenitors and IDH1 in mature luminal), possibly due to different levels 12 of (NAD(P)H) and demand of that in particular cell type 35 . Pyruvate generated from the 13 carbons of glucose is considered a major contributor to the TCA cycle, however luminal 14 progenitors did not display any enrichment of glycolytic enzymes. Interrogation of our 15 MEC metabolism map ( Figure S2 ) revealed numerous non-glycolytic mechanisms to 16 generate TCA cycle intermediates in luminal progenitors. This was the only population to 17 exhibit enrichment for enzymes involved in branched-chain amino acid catabolism 18 (modifying isoleucine, leucine and valine into acetyl-CoA) and was also strongly enriched 19 for proteins involved in β-oxidation (fatty acids into acetyl-CoA) ( Figure S2 ). Luminal 20 progenitors also had high level of PHGDH, a key enzyme in serine biosynthesis, shown 21 to contribute ~50% of the anaplerotic flux into the TCA cycle 31 ( Figure S2 ). This 22 engagement of diverse metabolic pathways that break down nutrients to feed the TCA 23 cycle underscores the strong preference of OXPHOS in this cell type. Altogether, 24 proteomes revealed that each mammary cell type has a distinct metabolic network, which 25 may represent the core set of metabolic proteins necessary for its structure and function. 26 27 Mitochondria Structure and Function is Mammary Cell Type-Specific 28 Next, we interrogated our published mouse mammary proteomic dataset 25 derived from 29 analogous MEC populations and found that metabolic proteomes clustered based on 30 mammary cell types ( Figure S3A and S3B), similar to human MECs ( Figure 1D ). Since 31 human luminal progenitors were endowed with TCA cycle and ETC proteins, we utilized 32 murine MECs cultured as a monolayer to examine their capacity to undergo OXPHOS as 33 measured by the Seahorse bioanalyzer (Figure 2A and 2B ). Specifically, we performed 34 the standard mitochondrial stress test, which quantifies oxygen consumption rate (OCR), 35 a readout for mitochondrial respiration, while exposing cells to inhibitors (Oligomycin, 36 Antimycin A) or enhancers (FCCP) of this process. At baseline respiration, basal cells 37 had the lowest level of OCR compared to either of the luminal populations ( Figure 2B ). 38 Even with the addition of FCCP, which boosts OCR, basal cells had OCR levels 39 comparable to or less than the baseline OCR of the two luminal cell types. Luminal progenitors and mature luminal cells had similar OCR profiles, except for maximal 1 respiration, which was significantly higher in luminal progenitors ( Figure 2B ). Thus, 2 mammary cell types have distinct capacities for mitochondrial respiration, with luminal 3 progenitors showing the highest OXPHOS capacity. 4 We next examined mitochondrial morphologies by transmission electron 5 microscopy (TEM) of pelleted FACS purified mouse MEC ( Figure 2C and S3C ). Basal 6 cells tended to have several small circular mitochondria with glossy cristae. This is similar 7 to the morphology of mitochondria in hematopoietic and embryonic stem cells 36 . In 8 contrast, luminal progenitors had long, tubular mitochondria with elaborate cristae. The 9 larger size of the mitochondria and higher cristae density are thought to be efficient in 10 supporting OXPHOS 37 , consistent with our data on OCR ( Figure 2B ). Mature luminal cells 11 surprisingly had indiscernible mitochondria, possibly due to the shearing stress 12 experienced by these larger cells during FACS. We performed intracellular flow cytometry 13 to further characterize the mitochondria ( Figure 2D ), using MitoTracker Green (MTG; total 14 level of mitochondria) and MitoTracker Red (MTR; mitochondrial activity). Both dyes 15 showed no significant differences among MECs ( Figure 2D ). CellROX and MitoSOX 16 measure cellular and mitochondrial reactive oxygen species (mROS), respectively.
17
Although total cellular ROS showed minimal differences, mROS levels varied significantly 18 ( Figure 2D ). Basal and mature luminal cells had equivalent high levels of mROS, whereas 19 luminal progenitors had the least amount despite having high mitochondrial respiration 20 ( Figure 2D ). These observations can be explained by the multiple antioxidant 21 mechanisms previously reported in luminal progenitors but not in basal cells 29 .
22
The high mROS levels in basal cells were intriguing, as they did not have high 23 OCR. This led us to ask whether the mitochondria had an alternative role in this population 24 beyond bioenergetics. The non-ATP functions of the mitochondria are becoming more 25 appreciated. For example, mitochondrial membrane potential has been linked to stem cell 26 capacity 38, 39 . We filtered our mouse and human MEC proteomes using MitoCarta, a 27 curated list of mitochondrial proteins 40 , and observed cell type-based clusters by 28 unsupervised hierarchical clustering ( Figure 2E ). Basal and luminal lineages are each 29 enriched for their own progenitors. We segregated MECs based on high (MTG hi MTR hi ) or 30 low (MTG hi MTR lo ) mitochondrial activity 41 , and enumerated luminal and basal progenitor 31 capacity using the colony-forming cell (CFC) assay ( Figure 2F ). Cells with high 32 mitochondrial activity had significantly greater CFC number than those with low 33 mitochondrial activity in both mammary lineages ( Figure 2E ). Basal, but not luminal, cells 34 with high mitochondrial activity also displayed enrichment of CFC capacity when 35 compared to their total unfractionated control. The EpCAM -CD49f hi basal cell 36 compartment contains mammary stem cells, basal progenitors and differentiated cells.
37
There is avid interest in teasing out new markers for progenitor-enriched basal subsets 38 and our data show that mitochondrial activity may serve such a role. Overall, our findings 39 also show that mitochondrial morphology and function varies with mammary cell type. 
Mammary Lineages Exhibit Differential Metabolic Vulnerabilities 2
We determined if metabolic distinctions of mammary lineages manifested as differential 3 sensitivity to various metabolic drugs using the CFC assay ( Figure 3A ). To inhibit 4 OXPHOS, we used complex-specific (RotenoneComplex I; Atpenin A5Complex II; 5 Antimycin AComplex III; OligomycinComplex V) and non-ETC inhibitors 6 (Tigecyclinemitochondrial ribosomes; UK5099Mitochondrial pyruvate carrier). Figure 1E and S2). Pathway analyses of the basal metabolic network had highlighted 23 glycolysis as the most significant term ( Figure 1E ). Our series of glycolytic drugs 24 demonstrated that basal CFCs were far more sensitive than luminal CFCs to all 4 25 compounds ( Figure 3C ). Collectively, this set of experiments demonstrates the lineage-26 specific metabolic vulnerabilities of mammary cells.
27

Breast Cancer Subtypes Retain Metabolic Features of their Putative Cell-of-Origin
28
To interrogated whether any of the PAM50 breast cancer subtypes had significant 29 enrichment of our MEC-specific metabolic network ( Figure 4A ) we performed single 30 sample gene set enrichment analysis (ssGSEA) 42 on breast cancer patients from the 31 METABRIC database 43 . We observed striking relationships between the metabolic 32 preferences of normal MEC and breast cancer subtypes ( Figure 4A ). Specifically, the 33 highly mesenchymal Claudin-low subtype was most enriched for the basal cell metabolic 34 network. The aggressive basal-like breast cancer was most significantly correlated to the 35 luminal progenitor metabolic network ( Figure 4A ). Luminal A and B subtypes showed 36 significant enrichment for the mature luminal metabolic network ( Figure 4A ). Thus, breast 37 cancer subtypes displayed strong activity for metabolic cluster of their proposed cell-of-origin, suggesting that breast cancers co-opt the metabolic network of their precursor 1 cells.
2
Recent studies have reported the successful targeting of metabolic vulnerabilities 3 which are specific to the tissue-of-origin 16, 44 or stem from chromosomal abnormalities 45, 46 . 4 We therefore used cBioportal 47, 48 to determine copy number amplifications in metabolic 5 genes within our MEC-specific networks in order to identify novel subtype-specific 6 metabolic targets. Interrogation of our luminal progenitor metabolic network revealed 7 PHGDH, a known amplified gene and selective vulnerability in ER-basal-like breast 8 cancers 31,49 , the subtype thought to originate from luminal progenitors. We identified 5 9 other highly abundant proteins in our mature luminal metabolic network, namely EPHX1, 10 NIT1, CYB5R1, GALNT2 and KMO, whose genes were amplified in ER+, PR+ as well as 11 most consistently in Luminal A and B breast cancers ( Figure 4B ). These 5 proteins do not 12 participate in the same metabolic pathway but are all found on chromosome 1q. Whole-13 arm amplification of 1q together with 16q loss (+/-) is a hallmark chromosomal event in 14 ER+ breast cancers 43, 50, 51 . The fact that we find metabolic network specific proteins being 15 amplified at the chromosome level in the respective breast cancer subtypes points to 16 these targets as possible cell-of-origin-specific metabolic vulnerabilities, which require 17 further investigation.
18
DISCUSSION
19
Using a combination of proteomics, characterization of the mitochondria and 20 pharmacological inhibition, we uncovered distinct metabolic identities of the three normal 21 mammary epithelial cell types ( Figure 4C ). This highlights a previously underappreciated 22 metabolic heterogeneity present in the epithelial compartment of the normal human and 23 mouse mammary gland. The observed lineage-drive metabolic programs may be intrinsic 24 to cell identity or a reflection of cellular adaptations to distinct mammary 25 microenvironments. Basal cells are in contact with the basement membrane which 26 separates the epithelial layers from a complex mammary stroma composed of immune 27 cells 52 , adipocytes 53 and fibroblasts 54 . Coversely, luminal cells are exposed apically to the 28 lumen of the mammary ductal tree. Since all our analyses were performed ex vivo on 29 purified mammary cells, we reason that metabolic distinctions are hardwired and likely 30 necessary to facilitate unique form and function of each mammary cell type. Our MEC-31 specific metabolic networks will enable further study into the influence of normal cells on 32 the metabolic phenotype of known breast cancer subtypes. In addition, global proteomes 33 of primary FACS-purified human and analogous mouse mammary cell types provide a 34 valuable resource to further understand the regulatory networks that define these different 35 epithelial lineages.
36
The metabolic phenotype of a cancer cell is dependent upon integrating multiple 37 intrinsic and extrinsic cues 55 . The importance of the tissue-of-origin in tumor metabolism 38 has now been established 13 . It has also been postulated that tumors located in the same 39 tissue but derived from different cell(s)-of-origin would display different metabolic properties, however this has never been experimentally shown 56 . Our work demonstrates 1 that part of the metabolic heterogeneity observed in breast cancers is instructed by the 2 diverse cellular origins of these cancers ( Figure 4C ). For instance, Claudin-low, Basal- as the cell-of-origin need to be considered in order to maximize the success of 9 personalized cancer medicine. Our study lays the foundation for rationalized targeting of 10 subtype-specific metabolic vulnerabilities, as informed by the metabolic networks of 11 mammary epithelial cells. and luteal) was determined by a pathologist examining breast specimens at UBC (Ramakrishnan 5 et al., 2002) . Reduction mammoplasty specimens were minced and enzymatically dissociated in 6 DMEM:F12 1:1 media with 15 mM HEPES plus 2% BSA, 1% penicillin-streptomycin, 5 g/ml 7 insulin, 300 U/ml collagenase (Sigma, C9891) and 100 U/ml hyaluronidase (Sigma, H3506) 8
shaking gently at 37°C, overnight or for 16-18 hours. Epithelial organoids were harvested by 9 centrifugation at 80g for 30 seconds and viably cryopreserved, as described previously (Labarge 10 et al., 2013) . 11
Human breast single cell suspensions: Human breast tissue organoids were thawed and 12 dissociated into single cell suspensions as reported previously (Eirew et al., 2010) . Briefly, 13
organoids were triturated in 0.25% trypsin-EDTA (Stem Cell Technologies, 07901) followed by 5 14 U/ml dispase (Stem Cell Technologies, 07913) and 50 g/ml DNase I (Sigma, D4513) as 15 described above for mouse samples, but for 5 minutes each. Cells were then washed in between 16 steps with HBBS + 2% FBS and filtered using a 40 m cell strainer. 17
Human breast FACS staining: For FACS staining, antibodies against CD45 (PECy7), CD31 18 (PECy7), EpCAM (APCCy7) and CD49f (FITC) were used. Lineage (Lin) positive cells were 19 defined as CD31 + CD45 + . Human mammary cell subpopulations were defined as: basal (Lin -20
EpCAM lo-med CD49f hi ); luminal progenitor (Lin -EpCAM hi CD49f med ); mature luminal (Lin -21
EpCAM hi CD49f lo ). Dead cells were excluded following doublet exclusion using DAPI. 22
Mice: All experiments were performed using 8-12 weeks old virgin female FVB wild-type mice 23 (The Jackson Laboratory or Charles River). Mice were ovariectomized bilaterally, then allowed 24 one week to recover. A slow-release 0.14 mg 17-β estradiol plus 14 mg progesterone pellet 25
(Innovative Research of America) was then placed subcutaneously near the thoracic mammary 26 gland for 2 weeks. This was done to obtain large quantities of viable mammary stem/progenitor 27 cells for subsequent analysis, as previously reported (Casey et al., 2018; Shiah et al., 2015) . All 28 mice were cared for according to guidelines established by the Canadian Council for Animal Care 29 under protocols approved by the Animal Care Committee of the Ontario Cancer Institute. 30
Mouse mammary single cell suspensions:
Harvested mammary glands were manually minced 31
with scissors for 2 minutes, and then enzymatically dissociated using 750 U/ml collagenase and 32 250 U/ml hyaluronidase (Stem Cell Technologies, 07912) and diluted in DMEM:F12 for 1.5 hours.
33
Samples were vortexed at the 1-and 1.5-hour mark. Red blood cells were lysed using ammonium 34 chloride (Stem Cell Technologies, 07850). Cells were then mixed in trypsin-EDTA (0.25%, Stem 35
Cell Technologies, 07901) that had been pre-warmed to 37°C using a 1mL pipette for 2 minutes. 36
Next, they were washed in Hanks Balanced Salt Solution (HBSS) without calcium or magnesium 37 plus 2% FBS and centrifuged at 350g. Finally, cells were mixed in dispase 5 U/ml (Stem Cell 38
Technologies, 07913) plus 50 g/ml DNase I (Sigma, D4513) for 2 minutes, washed in HBBS + 39 2% FBS and filtered using a 40 m cell strainer to obtain single cells. 40
Mouse mammary FACS staining: Dead cells were excluded following doublet exclusion using 1 DAPI or Zombie UV Fixable Viability Kit (BioLegend) according to manufacturer's instructions. 2
For FACS staining, antibodies against TER119 (PECy7 or eFluor450), CD31 (PECy7 or 3 eFluor450), CD45 (PECy7 or eFluor450), EpCAM (APCCy7), CD49f (FITC or PECy7), CD49b 4 (PE) and Sca-1 (APC or Brilliant Violet 711) were used. Lineage (Lin) positive cells were defined 5
as Ter119 + CD31 + CD45 + . Mouse mammary cell subpopulations were defined as: total basal (Lin -6
EpCAM lo-med CD49f hi ); total luminal (Lin -EpCAM hi CD49f lo ); luminal progenitor (Lin -7
EpCAM hi CD49f lo CD49b + Sca-1 -); mature luminal (Lin -EpCAM hi CD49f lo CD49b -/+ Sca-1 -/+ ). High and 8 low mitochondrial activity populations were defined as MitoTracker Red Hi MitoTracker Green hi and 9
MitoTracker Red lo MitoTracker Green hi , respectively, and applied after gating for total luminal and 10 basal populations. Fluorophores are specifically mentioned in individual figures. Cell sorting was 11 performed on a BD FACSAria™ II. 12
Mouse CFC assay: 350 cells of the specified FACS-purified population were seeded together 13 with 20,000 irradiated NIH 3T3 cells in a 6-well plate. Cells were cultured for 7 days at 5% oxygen 14
in EpiCult-B mouse medium (Stem Cell Technologies, 05610) supplemented with 5% FBS, 10 15 ng/ml EGF, 20 ng/ml basic FGF, 4 μg/ml heparin, and 5 μM ROCK inhibitor (Millipore). Cells were 16
allowed to adhere for 24 hours, and then either vehicle control (0.1% DMSO) or the indicated 17 concentrations of inhibitors were added for the remaining six days. 18
Mammary cell intracellular flow cytometry: All intracellular dyes were used to stain cells prior 19
to cell surface marker staining protocol. Staining for total mitochondria (50 nM MitoTracker Green 20 FM, Thermo Fisher, M7514), mitochondrial activity (250 nM MitoTracker Red CMXRos, Thermo 21
Fisher, M7513), mitochondrial ROS (5 μM MitoSOX, Thermo Fisher, M36008), and cytosolic ROS 22
(5 μM CellROX Green, Thermo Fisher, C10492) was performed by incubating cells at 37°C for 23 20-30 minutes following the manufacturer's protocols and directly analysed without fixing. Cell 24 analysis was performed in BD Biosciences Fortessa. Median fluorescent intensity (MFI) refers to 25 the fluorescence intensity of each event (on average) of the selected cell population, in the chosen 26 fluorescence channel (PE Texas Red or FITC) and was determined by using the flow cytometry 27 analysis software FlowJo. 28
Metabolic inhibitors used in vitro:
Vehicle and drugs were added such that the final 29 concentration of DMSO did not exceed 0.1% (vol/vol). The following drugs were used in this study:
Genomics Consortium), rotenone (Sigma; R8875), tigecycline (CarboSynth, 220620-09-7), 32
antimycin A (Sigma, A8674), oligomycin (Sigma, 75351), atpenin A5 (Cayman Chemicals, 33 11898), UK-5099 (Sigma, PZ0160), galloflavin (Sigma; SML0776). 34
Transmission electron microscopy: Mammary epithelial cells were FACS-purified from 3 EP-35 treated ovariectomized 8-12 week old mice. Cells were pooled together to increase yield and then 36 pelleted for 5 mins at 4°C at max speed. Supernatant was removed and then fixed with 2% 37 glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.3, without disturbing the pellet. Samples 38
were processed by the Nanoscale Biomedical Imaging Facility (SickKids, Toronto, ON). Images 39
were acquired using the FEI Technai 20 transmission electron microscope. Scale bars are specific 40 to images. 41 Seahorse: MEC subpopulations (Luminal progenitor, mature luminal and basal cell) were FACS-1 purified from unstaged mice and 10,000 cells were plated into each well of collagen pre-coated 2
Seahorse plates. The cells were culutred in the 5% O2 incubator for 6 days to reach at least 80-3 90% confluence. On the 7th days, cells were switched to DMEM:HAM's F12 with no bicarbonate 4 containing 5% FBS, insulin (Thermo Fisher, 12585014), EGF (STEMCELL Technologies; 5 78006.1), bFGF (STEMCELL Technologies), hydrocortisone (STEMCELL Technologies, 6 78003.1), Rock inhibitor (Millipore, SCM075) in 5% oxygen conditions. Then the plate was allowed 7
to equilibrate for 1 hour in the Seahorse incubator. Inhibitors used for the assay include oligomycin 8
(2 μM), FCCP (1 μM, Sigma, C2920) and antimycin A (1 μM). After the assay, cell viability was 9 determined using the CyQUANT nuclear dye (Thermo Fisher, C35007). Data was analyzed on 10 the WAVE platform and normalized to the number of live cells determined after the viability assay. 11
Proteomics on FACS-purified human mammary subpopulations: For Liquid 12
Chromatography-Mass Spectrometry (LC-MS) of human mammary subpopulations, 100,000 cells 13 from each population were isolated from each patient, as described (Casey et Carbamidomethylation of cysteine was specified as a fixed modification and oxidation of 33 methionine was specified as a variable modification. Proteins were identified with a minimum of 34 two razor+unique peptides, the maximum false peptide discovery rate was specified as 1%, and 35
"match between runs" was enabled. were used to discover uniquely expressed proteins in each cell type. Averages across samples 7
in each cell type were taken, resulting in one mean expression value for each protein in each cell 8 type (nBC = 9, nLP = 10, nML = 10). Next, the values of zero for each cell type and associated 9 proteins were excluded from the analysis. Number of proteins expressed in each cell type were 10 summarized in a Venn diagram, created using the "VennDiagram" R package (version 1.6.20) 11
(Chen and Boutros, 2011). Gene set enrichment was conducted on the same values. Mean 12 expression values for each protein in each of the cell types were ranked according to descending 13 log2 median intensities and grouped into deciles. The protein with the highest intensity received 14 a rank of 1 and thus, was placed in the first decile. Meanwhile, the protein with the lowest mean 15
intensity received a rank of y and was placed in the tenth decile, where y represents the total 16
number of proteins detected in a particular cell type. Pathway analysis via the "enrichR" R 17 package (version 1.0) was conducted on the proteins in each decile (Chen et al., 2013; Kuleshov 18 et al., 2016) . 19 20
Principal component analysis (PCA) was performed by calculating Euclidean distances of scaled 21 expression values. PCA scores were plotted in a plane defined by the first two components (that 22
is, PC1 and PC2) using the "ggbiplot" R package (Vu, 2019) . Ellipses were drawn around cell 23 type clusters, where centroids were the barycentre of each cluster and the diameter represented 24 the maximum variance. 25 26
Heat maps depicted z-scores of protein expression values (x) computed using the formula: (x -27 mean(x))/standard_deviation(x). Divisive hierarchal clustering dendograms of Pearson distance 28 matrices for samples and proteins were created using DIANA (DIvisive ANAlysis Clustering) 29 method in the "cluster" R package (version 2.0.7-1) (Maechler et al.) . Heat maps were plotted 30 using the "pheatmap" (version 1.0.12) and "RColorBrewer" (version 1.1-2) R packages (Kolde, 31 2019; Neuwirth, 2014). 32 33
Metabolic Cluster Derivation and Pathway Analysis: A metabolic proteome was obtained by 34
filtering the total proteome using a curated list of 2753 genes that encompasses all known human 35 metabolic enzymes and transporters (Possemato et al., 2011) . Based on matching by gene 36 symbols, 1020 proteins related to metabolism were found in the total proteome of 6034 proteins, 37
including "PKM" which was not identified in the curated list. As multiple protein groups in the 38 proteome shared the same gene symbols, duplicates were included in the analysis. Metabolic 39 signatures were acquired by looking at proteins in which mean expression met the fold-change 40
and statistical change cut-offs in each cell type compared to the other two cell types (nBC = 9, nLP 41 = 10, nML = 10). The log2 fold-change (FC) cut-off was greater than 0 and the statistical 42 significance cut-off was P < 0.05 in a one-way ANOVA and Tukey's multiple comparisons test. 43
Pathway analysis of metabolic clusters was conducted using Enrichr 44 (https://amp.pharm.mssm.edu/Enrichr/). Enrichr is a comprehensive gene set enrichment tool that 1 is available both as a web interface (Chen et al., 2013) and an R package (Kuleshov et al., 2016) . 2
It queries a list of gene symbols and returns commonly annotated pathways by searching large 3 gene set libraries. The gene set library selected for our analysis was Gene Ontology Biological 4
Process (GOBP) 2018. For each cell-type signature, the top ten GOBP terms enriched by gene 5 sets were sorted by lowest to highest combined score (ln(p-value) *z-score), a metric used by 6
Enrichr to find the best ranking terms compared to other methods. 7 8
Correlations to PAM50 Breast Cancer Subtypes: Gene expression for PAM50 breast cancer 9
subtypes ( Hits" bar is a metabolic protein whose expression was significantly enriched in only 19 one cell type using a one-way ANOVA in conjunction with Tukey's test (p<0.05) and 20 colour-coded for that cell type.
21
E. Bar graphs summarize the top 10 most significant GO biological processes according 1 to Enrichr for each cell type's metabolic network. Enrichr calculates a combined 2 score, a metric used to find the best terms. Workflow: Basal-like Luminal Progenitor Mature Luminal Basal Cell 
